Manmohan Undergoes Surgical Operation At AIIMS

New Delhi: For benign enlargement of the prostate gland, Prime Minister Dr. Manmohan Singh today went through a surgical operation at the All India Institute of Medical Sciences (AIIMS).

Sanjaya Baru, Manmohan’s Media Adviser stated that the operation took place to treat benign prostatic dysplasia of the prostate gland.

“The Prime Minister was recovering and has had a stable post operative course,” Mr. Baru added.

For the next two days, Mr. Singh will stay at hospital, and it is likely that he will go back home by Monday morning.

Pratibha Gives Away 53rd National Film Awards

New Delhi: President Pratibha Patil gave away the 53rd National Film Awards for the year 2005, and also presented far-famed film producer Shyam Benegal with the Dadasaheb Phalke Award at the dazzling ceremonial occasion.

While lecturing at the function, Patil emphasized on the uniqueness of the films, adding up that country’s rich history, traditions and background presents a strong base for the novelty and uniqueness of the Indian cinema.

ZTE Looking For Indian Mate For R&D

Shenzhen (China): ZTE is making exploratory survey for Indian partners in order to start research and development in broadband and internet protocol TV (IPTV) products.

Two ASI Officials Suspended Over Ram Setu Controversy

New Delhi: Two functionaries of Archaeological Survey of India (ASI) have been suspended over Ram Setu affidavit controversy.

One of the suspended officials was the director administration whereas the other was of the grade of assistant director.

Both were accountable for the drafting of the affidavit with the divisive citations to Ram that resulted to a storm of protestations.

FDA Okays New Blood Typing Examinations

Washington: The U.S. Food and Drug Administration has approved 15 new blood typing examinations intended to perk up the safety of blood transfusion.

The tests that were previously unavailable in the US are called blood grouping reagents.

The FDA has stated that the tests find out the blood type of blood donors, a vital step in guaranteeing safe blood transfusion for patients. If incompatible blood is administered to a patient, it may cause a grave and possibly deadly reaction.

Satyam To Drive Europe-Asia Market Through Acquisitions

Mumbai: Satyam Computer Services Ltd is concentrating on mounting its earnings from European as well as Asian markets, and is looking at developing both geographically plus through acquirements. Rising verticals including energy and utilities, retail, media and entertainment and travel, transport & logistics will be its key growth drivers in the worldwide foray.

Pages

News in Focus

InterGlobe Aviation (INDIGO) Share Price Target at Rs 5,500: Emkay Research

Emkay Research has issued a BUY recommendation on InterGlobe Aviation (IndiGo), setting a revised target price of Rs5,500, implying a potential upside of approximately 31.5% from the current market

CCL Products (India) Share Price Target at Rs 1,350: Geojit Financial Services

Geojit Financial Services has issued a ‘BUY’ recommendation on CCL Products (India) Ltd., highlighting strong earnings momentum, improving balance sheet strength, and a technically bullish setup.

Emami Shares Price Dips to Yearly Lows; Emami Acquires 100% Stake in Axiom Ayurveda

Emami share price touched 52-week lows during Thursday's trading session but the stock recovered by the end of the day. Emami touched Rs 385.5 but ended the day 1.3 percent higher at Rs 398.5.

Premier Energies, Waaree Energies, ONGC, Oil India Shares Could See Slight Upside: Yes Securities

Premier Energies, Waaree Energies, ONGC, Oil India shares could see higher levels in upcoming sessions as markets can recover after US President Donald Trump's announcement of withdrawing from Iran

Swiggy Share Price Target at Rs 460: HDFC Securities

HDFC Securities has reiterated a BUY call on Swiggy, underscoring a compelling valuation opportunity after a sharp ~37% correction over the past six months.

Eternal (Zomato) Share Price Could Reach Rs 340: HDFC Securities

HDFC Securities has upgraded Eternal to a BUY rating, maintaining a target price of Rs 340, signaling a compelling upside from current levels.